Online citations, reference lists, and bibliographies.
← Back to Search

Preparation, Characterization And Cell Based Delivery Of Stavudine Surface Modified Lipid Nanoparticles

R. Shegokar, K. Singh
Published 2012 · Materials Science

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Previously it was shown that uncoated lipid nanoparticles of stavudine proved effective in targeting HIV viral sites in body. Therefore, the main objective of this work was to prepare and characterize surface modified stavudine entrapped lipid nanoparticles as potential drug delivery system for anti-HIV chemotherapy. The physical, targeting potential (both in vitro and in vivo) and toxicological evaluation was performed on developed nanocarriers. The degree of targeting and cellular uptake demonstrated differences among the surface coated lipid nanoparticles. We found that developed lipid nanoparticles are easy to prepare using high pressure homogenization, and has excellent stability at room temperature and refrigeration condition. In future, developed surface modified lipid nanoparticles can be evaluated clinically.
This paper references
10.1016/J.JCONREL.2005.07.014
Physico-chemical characterization of polysaccharide-coated nanoparticles.
C. Lemarchand (2005)
10.1159/000030124
Cell Adhesion Inhibition by Glycoliposomes: Effects of Vesicle Diameter and Ligand Density
R. Stahn (2000)
10.1016/S0168-3659(00)00367-9
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation.
H. M. Redhead (2001)
Conversion of stavudine lipid nanoparticles into dry powder
R. Shegokar (2011)
183-189
R Cavalli (2012)
10.1016/0167-4889(82)90120-3
Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages.
M. J. Hsu (1982)
Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge.
M. Amiji (2006)
10.1016/j.ijpharm.2011.09.041
Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation.
R. Shegokar (2011)
10.1143/JJAP.47.2068
Chemical Modification of Carbon Nanotube Based Bio-Nanosensor by Plasma Activation
T. Hirata (2008)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1111/j.1745-7254.2005.00216.x
Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles
M. Huang (2005)
10.1016/j.addr.2009.11.021
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.
S. Gunaseelan (2010)
10.1016/j.ijpharm.2008.08.050
Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles.
Y. Kuo (2009)
10.1016/S0378-5173(96)04782-5
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
10.1016/S0169-409X(00)00070-3
Lectin-mediated mucosal delivery of drugs and microparticles.
M. A. Clark (2000)
Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs.
R. Shegokar (2011)
10.1093/JAC/DKH411
Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
A. Sharma (2004)
10.1152/AJPGI.2001.280.5.G879
In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein.
P. Opanasopit (2001)
10.1021/BM700857S
Stable stealth function for hollow polyelectrolyte microcapsules through a poly(ethylene glycol) grafted polyelectrolyte adlayer.
Uta Wattendorf (2008)
10.1016/j.ijpharm.2010.08.014
Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.
R. Shegokar (2011)
10.1007/s11095-008-9615-2
Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line
N. Chattopadhyay (2008)
10.1016/j.addr.2009.11.017
Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.
J. das Neves (2010)
10.1016/J.NANO.2007.02.002
Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
H. Agashe (2007)
10.1016/j.colsurfb.2008.07.013
Heparin coating of poly(ethylene terephthalate) decreases hydrophobicity, monocyte/leukocyte interaction and tissue interaction.
P. H. J. van Bilsen (2008)
Toxicokinetics of 2',3'-didehydro-3'-deoxythymidine, stavudine (D4T).
S. Kaul (1999)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
10.1016/0304-4165(81)90259-2
Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles.
Y. Kao (1981)
264-271
R Shegokar (2012)
10.1080/10611860500071292
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
T. Göppert (2005)
Albumin adsorption on stealth and non-stealth solid lipid nanoparticles
R. Cavalli (1999)
10.1016/J.BBAMEM.2007.09.033
Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery.
Heike Bakowsky (2008)



This paper is referenced by
10.1007/978-3-319-11728-7_6
Nanotoxicity: Must Consider Aspect of Nanoparticle Development
R. Shegokar (2015)
10.1080/08982104.2018.1551408
Dextrose modified bilosomes for peroral delivery: improved therapeutic potential and stability of silymarin in diethylnitrosamine-induced hepatic carcinoma in rats
Poonam Parashar (2018)
Advancements in Novel Drug Delivery Systems and Opportunities for Indian Pharmaceutical companies
G KumarBabu (2015)
Research and Reviews; Journal of Pharmaceutics and Nanotechnology
Nagashree Kotturi (2015)
NANOEMULSION: An Effective Drug Carrier for the Management of Psoriasis
Rimmi Singh (2015)
10.1080/17425247.2020.1762565
Macrophage targeted nanocarrier delivery systems in HIV therapeutics
Tabassum Khan (2020)
10.1016/B978-0-12-801317-5.00014-1
Nanotechnology—Is There Any Hope for Treatment of HIV Infections or Is It Simply Impossible?
R. Shegokar (2015)
10.1080/17425247.2020.1783237
Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer
Mahwash Mukhtar (2020)
10.1016/B978-0-323-46142-9.00030-X
Role of Excipients in formulation development and biocompatibility of lipid nanoparticles (SLNs/NLCs)
S. Doktorovová (2017)
10.1007/978-3-030-06115-9
Surface Modification of Nanoparticles for Targeted Drug Delivery
Param Patel (2019)
Advancements in Novel Drug Delivery Systems and Opportunities for Indian Pharmaceutical companies
K. Babu (2015)
Nano-gels a Potential Carrier for Nanomedicine: A Review
Jagmeet Singh (2016)
NANOEMULSION: An Effective Therapy for Transdermal Drug Delivery
Rimmi Singh (2015)
10.4155/TDE-2016-0038
Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.
Hasan Ali (2016)
Semantic Scholar Logo Some data provided by SemanticScholar